[1] [1] HOWARD A D, WANG R, PONG S S, et al. Identification of receptors for neuromedin U and its role in feeding［J］. Nature, 2000, 406(6791): 70-74.

[2] [2] WU Y, MCROBERTS K, BERRS S, et al. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia［J］. Oncogene, 2007, 26(5): 765-773.

[3] [3] ALEVIZOS I, MAHADEVAPPA M, ZHANG X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis［J］. Oncogene, 2001, 20(43): 6196-6204.

[4] [4] YAMASHITA K, UPADHYAY S, OSADA M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma［J］. Cancer Cell, 2002, 2(6): 485-495.

[5] [5] TOKUMARU Y, YAMASHITA K, OSADA M, et al. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing［J］. Cancer Research, 2004, 64(17): 5982-5987.

[6] [6] SHETZLINE S E, RALLAPALLI R, DOWD K J, et al. Neuromedin U: a Myb regulated autocrine growth factor for humanmyeloid leukemias［J］. Blood, 2004, 104(6): 1833-1840.

[7] [7] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA: A Cancer Journal for Clinicians, 2018, 68(6): 394-424.

[8] [8] CIRIELLO G, GATZA M L, BECK A H, et al. Comprehensive molecular portraits of invasive lobular breast cancer［J］. Cell, 2015, 163(2): 506-519.

[11] [11] LEA A J, VOCKLEY C M, JOHNSTON R A, et al. Genome-wide quantification of the effects of DNA methylation on human gene regulation［J］. Elife, 2018, 7: e37513.

[12] [12] ZHANG C L, ZHAO N, ZHANG X, et al. SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis［J］. Brief Bioinform, 2020, 22(3): bbaa162.

[13] [13] CHANDRASHEKAR D S, BASHEL B, BALASUBRAMANYA S A H, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses［J］. Neoplasia, 2017, 19(8): 649-658.

[14] [14] ASPLUND A, EDQVIST P H D, SCHWENK J M, et al. Antibodies for profiling the human proteome—the Human Protein Atlas as a resource for cancer research［J］. Proteomics, 2012, 12(13): 2067-2077.

[15] [15] KIRSZ K, ZIEBA D A. The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis［J］. Advances in Hygiene & Experimental Medicine, 2012, 66: 196-203.

[16] [16] GARTLON J, SZEKERES P, PULLEN M, et al. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats［J］. Psychopharmacology, 2004, 177(1/2): 1-14.

[17] [17] WATTEYNE J, PEYMEN K, VAN DER AUWERA P, et al. Neuromedin U signaling regulates retrieval of learned salt avoidance in a C. elegans gustatory circuit［J］. Nat Commun, 2020, 11(1): 2076.

[19] [19] WAN Y, ZHANG J, FANG C, et al. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens［J］. Peptides, 2018, 101: 69-81.